3 withdrawn. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Withdrawn 3 |
Follow Resection: new trials by email Literature Review of Resection trials Research Report on Resection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Peptide-Pulsed Dendritic Cell Vaccination in Combination With Nivolumab and Ipilimumab for the Treatment of Recurrent and/or Progressive Diffuse Hemispheric Glioma, H3 G34-mutant Dendritic Cell Tumor Peptide Vaccine, Ipilimumab, Leukapheresis - Diffuse Hemispheric Glioma, H3 G34-Mutant | Phase 1 | Withdrawn | Jonsson Comprehensive Cancer Center | 2024-12-01 | 2025-02-24 | |
| Trotabresib in Combination With Vinorelbine and Radiation Therapy for the Treatment of HER2+ Breast Cancer With Central Nervous System or Leptomeningeal Metastasis Biospecimen Collection, Computed Tomography, Magnetic Resonance Imaging - Breast Carcinoma, Metastatic Malignant Neoplasm in the Brain | Phase 1 | Withdrawn | Northwestern University | 2023-12-31 | 2024-04-01 | |
| ONC201 and Radiation Therapy Before Surgery for the Treatment of Recurrent Glioblastoma Akt/ERK Inhibitor ONC201, Radiation Therapy, Resection - Recurrent Glioblastoma, Recurrent Gliosarcoma | Phase 1 | Withdrawn | Jonsson Comprehensive Cancer Center | 2021-05-01 | 2021-05-12 |
Brain Neoplasms (1) · Breast Neoplasms (1) · Glioblastoma (1) · Gliosarcoma (1) · Meningeal Carcinomatosis (1)
Jonsson Comprehensive Cancer Center (2) · Northwestern University (1)
United States (3)
Anthony C Wang (1) · Phioanh Nghiemphu (1) · Roger Stupp, MD (1)
P30CA060553 (1), P50CA211015 (1)